Dr. Floyd Christopher Holsinger, MD

Dr. Holsinger practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Holsinger's NPI, 1922192657, was assigned on October 3, 2006. Dr. Holsinger graduated from Vanderbilt University School Of Medicine in 1995. Dr. Holsinger holds California license C54859.

Dr. Holsinger's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Holsinger's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Holsinger is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Holsinger to 1 more hospital and 1 medical group, each named with a free account. Dr. Holsinger's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holsinger practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Holsinger's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Holsinger is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Holsinger's licenses on file in 2 states: California and Texas.

Dmand AI lists chronic sinusitis, larynx and vocal cord disease and thyroid surgery among the conditions Dr. Holsinger treats.

CMS data shows 450 Medicare services from Dr. Holsinger across 5 procedure codes in 2024, for 206 Medicare patients. Medicare paid $62,377 for them.

CMS counts 206 Medicare patients who saw Dr. Holsinger in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holsinger's median patient age at 63, with 39% women.

In 2024, Dr. Holsinger wrote 14 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Holsinger for performance year 2024, reported as part of a group. Dr. Holsinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holsinger as offering telehealth.

Dmand AI links 213 papers to Dr. Holsinger, published from 2009 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Robotic Surgical Procedures. Dr. Holsinger has published most often in Head Neck. Dr. Holsinger's most frequent co-authors are Ryan Kenneth Orosco, MD, Adel K. El-Naggar, MD, PhD and Jeffrey N. Myers, FACS, MD, PhD.

CMS Open Payments shows 9 general payments to Dr. Holsinger from 5 drug and device companies from 2020 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Lumenis, Inc paid the most, $2,000.

Dmand AI lists 15 awards for Dr. Holsinger, most recently Fellows’ Teaching Award, Department of Head and Neck Surgery in 2013.

Dr. Holsinger graduated from Vanderbilt University School Of Medicine in 1995. Dr. Holsinger is a member of ACS.

Dr. Holsinger is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.